Apogee Therapeutics, Inc.

APGEDelisted Sep 3, 2026

Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001974640

SEC filings (opens in a new tab)

Apogee Therapeutics, Inc. was delisted on Sep 3, 2026; its insiders filed their last Form 4 on Sep 3, 2026; 288 institutions reported holding it in 13F filings for Q2 2026, worth $8.93B in total; Soros Fund Management was the only superinvestor holding it.

Q3 2024 vs. Q2 2024

How the institutions holding Apogee Therapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of APGE: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	139	1	139	+1
Shares	54.2M	2.74M	56.1M	+4.68M (+9.1%)
Value	$2.13B	$107.9M	$3.29B	+$1.27B (+62.7%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Apogee Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to APGE in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	2,975,917	$174.8M	0.00%
Waypoint Capital Advisors, LLC	627,089	$36.8M	7.84%
Frontier Capital Management Co LLC	311,316	$18.3M	0.17%
Boxer Capital, LLC	179,000	$10.5M	0.52%
Vestal Point Capital, LP	136,500	$8.02M	0.63%
Granahan Investment Management Inc	91,757	$5.39M	0.21%
Natixis Advisors, L.P.	14,968	$879.0K	0.00%
Bayesian Capital Management, LP	11,878	$697.7K	0.08%
Exane Asset Management	10,100	$593.3K	0.47%
AlphaCentric Advisors LLC	8,500	$499.3K	0.37%
SG Americas Securities, LLC	8,094	$475.0K	0.00%
Caption Management, LLC	7,540	$442.9K	0.05%
FORA Capital, LLC	6,789	$398.8K	0.05%
Valence8 US LP	5,240	$307.8K	0.13%
Intech Investment Management LLC	5,100	$299.6K	0.00%
Teacher Retirement System of Texas	4,841	$284.0K	0.00%
Wexford Capital LP	3,922	$230.4K	0.06%
E Fund Management Co., Ltd.	3,506	$205.9K	0.01%
Acadian Asset Management LLC	2,401	$141.0K	0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)	1,207	$70.9K	0.00%
Sterling Capital Management LLC	37	$2.17K	0.00%
Bessemer Group Inc	30	$2.00K	0.00%
Simplex Trading, LLC	38	$2.00K	0.00%
Credit Agricole S A	2,057	$1.21K	0.00%
Capital Performance Advisors LLP	13	$764	0.00%
Parallel Advisors, LLC	11	$646	0.00%

Sold out (25)

Institutions that held Apogee Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of APGE in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Deerfield Management Company, L.P. (Series C)	329,000	$12.9M
First Turn Management, LLC	318,327	$12.5M
Polar Capital Holdings Plc	250,000	$9.84M
Renaissance Technologies LLC	156,204	$6.15M
Citadel Advisors LLC	116,318	$4.58M
Trexquant Investment LP	87,201	$3.43M
Integral Health Asset Management, LLC	80,000	$3.15M
Sio Capital Management, LLC	78,000	$3.07M
Artia Global Partners LP	58,400	$2.30M
Adage Capital Partners GP, L.L.C.	50,000	$1.97M
Jump Financial, LLC	43,458	$1.71M
Superstring Capital Management LP	36,928	$1.45M
Walleye Capital LLC	30,178	$1.19M
XTX Topco Ltd	17,930	$705.5K
HRT Financial LP	15,745	$619.0K
Norges Bank	12,121	$477.0K
AQR Capital Management LLC	11,535	$453.9K
Gsa Capital Partners LLP	10,312	$406.0K
Omers Administration Corp	9,500	$373.8K
Centiva Capital, LP	6,437	$253.3K
Paloma Partners Management Co	5,100	$200.7K
Pacer Advisors, Inc.	426	$16.8K
Macquarie Group Ltd	305	$12.0K
Smartleaf Asset Management LLC	3	$119
The PNC Financial Services Group, Inc.	2	$79

Not filed for Q3 2024 yet (1)

Institutions that held Apogee Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding APGE in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	2,742,549	$107.9M